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Abstract
Background: The health benefits of increased intakes of omega-3 fatty acids are well established
but palatability often presents a problem. The process of emulsification is used in the food industry
to provide a wider spectrum of use, often with the result of increased consumption. Moreover, as
emulsification is an important step in the digestion and absorption of fats, the pre-emulsification
process may enhance digestion and absorption. In this study the levels of plasma fatty acid and
triacylglycerol (TAG) following the ingestion of either an oil mixture or an emulsified oil mixture
have been compared.
Methods: In this randomised cross-over study, 13 volunteers received the oil mixture and 11
received the oil emulsion as part of an otherwise fat free meal. Blood samples were collected at 0,
1.5, 3, 4.5, 6, 7.5 and 9 hours after ingestion of oil, separated and stored at -20°C. Plasma
triacylglycerols were assessed spectrophotometrically and fatty acids were determined by gas
chromatography. Following a washout period of twenty days the procedure was repeated with the
assignments reversed.
Results: The postprandial plasma TAG and the C18:3 (n-6), C18:3(n-3), C20:5(n-3) and C22:6 (n-
3) polyunsaturated fatty acid (PUFA) levels for the emulsified oil group were increased significantly
(P = 0.0182; P = 0.0493; P = 0.0137; P < 0.0001; P = 0.0355 respectively) compared with the non-
emulsified oil group. The C16:0 and C18:0 saturated fatty acids, the C18:1 (n-9) monounsaturated
fatty acid and the C18:2 PUFA were not significantly different for the oil and emulsified oil groups.
Conclusion: Pre-emulsification of an oil mixture prior to ingestion increases the absorption of
longer chain more highly unsaturated fatty acids (especially eicosapentaenoic acid and
docosahexaenoic acid) but does not affect absorption of shorter chain less saturated fatty acids,
suggesting that pre-emulsification of fish oils may be a useful means of boosting absorption of these
beneficial fatty acids. 
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Background
The biochemical importance of dietary lipids to human
physiology and nutrition is now firmly established and
research continues to show potential health benefits of
polyunsaturated fatty acids (PUFAs) and in particular the
omega-3 fatty acids both from fish and precursors of the
same family found in many plant oils [1-3].
Current UK recommendations advise the public to eat at
least two portions of fish every week including one of oily
fish, which is rich in omega-3 PUFAs, or take >200 mg/
day of omega-3 PUFAs [4]. According to the WHO, one
portion should provide an equivalent of 200–500 mg of
eicosapentaenoic acid (EPA) and docosahexaenoic acid
(DHA) [5]. In fact most people in the UK consume con-
siderably less than one portion per week [4] indicating
that the recommended levels are not being achieved leav-
ing fish oil supplementation as the most convenient route
to augment dietary intake. However, reaching recom-
mended intake levels may require taking several capsules
of fish oil per day. An alternative is to use a more palatable
version of liquid fish oils presented as a flavoured emul-
sion which may offer a more flexible route to achieve the
required level of intake.
Approximately 95% of dietary lipids ingested from foods
consist of triacylglycerols (TAGs) and lipid digestion is
initiated by the action of lingual/gastric lipases which
together with the physical mixing action of the stomach
produces small partially emulsified droplets containing
mainly TAGs but also free fatty acids (FFA) and diacylglyc-
erols. Further emulsification together with the action of
pancreatic lipase results in the production of 2-monoa-
cylglycerols (sn2-MAG) and free fatty acids and these are
incorporated into mixed micelles before passive diffusion
into the enterocyte [6,7]. Once inside the enterocyte the
fatty acids with less than 12 carbon atoms pass directly
into the hepatic portal vein [6]. However, most dietary
fatty acids have a chain length greater than 12 and these
are re-synthesised into TAG and incorporated into the
chylomicron (CM) family of lipoproteins [7], which are
secreted into the lymphatic system and transported to the
thoracic lymphatic duct where they enter the circulation
[8]. The fatty acid composition of the core of the CM –
TAG generally reflects the dietary fatty acid profile, partic-
ularly in the first 4–6 hours postprandial period [9]. The
CM-TAGs are rapidly hydrolysed by lipoprotein lipase
(LPL) releasing between 70–90% of the total TAG and
leaving chylomicron remnants which are removed from
the plasma via low density lipoprotein (LDL) receptors in
the liver [10,11].
There have been conflicting observations that the use of
emulsified forms of fish oils in some studies has led to
improved digestion and absorption of EPA and DHA
[12,13] with other work showing no differences in
absorption [14]. Preliminary research in our laboratory
has indicated that both the rate and extent of absorption
of the fatty acids EPA and DHA improve if the oil is pre-
emulsified prior to ingestion. This cross – over absorption
study was designed to establish whether pre-emulsifica-
tion of an oil mixture leads to improved absorption of
fatty acids, particularly DHA and EPA, compared with the
non-emulsified form of the oil mixture.
Methods
Subjects
Twenty four healthy volunteers (14 females and 10 males,
5 smokers) were enrolled into the study. The mean age of
participants was 35.13 ± 11.59 years and their BMI was
24.66 ± 5.19 kg/m2. Volunteers were excluded from the
study if they had been involved in dietary control, were
receiving long-term medication for the chronic diseases,
were obese or had very low body weight, had diagnosed
hypercholesterolemia, coronary artery disease or diabetes.
Participants who were taking dietary fatty acid supple-
ments were also excluded.
All volunteers provided written informed consent before
participating in the present study and ethical permission
was obtained from Iechyd Morgannwg Health, Local
Research Ethics Committee, United Kingdom.
Study design and diet
In a cross-over study, participants were randomly assigned
to receive either the oil mixture or oil emulsion mixture,
with thirteen subjects receiving oil and eleven subjects
receiving oil emulsion in the first stage.
The mixtures of oils (comprising: concentrated fish oil
43%, borage oil 31% and flaxseed oil 26%) in both the
natural form and in the emulsified form were supplied by
Cultech Ltd., Port Talbot, United Kingdom. The fatty acid
composition of the oil preparations is shown in Table 1.
The participants fasted for 12 hours prior to the study.
Subjects consumed 30 ml of oil as part of a meal compris-
ing fat free cereal (37.5 g), skimmed milk (230 ml), sugar
(4 g) and apple juice (150 ml). For the remainder of the 9
hour collection period the participants ate only boiled rice
(100 g), boiled pasta (100 g) and fresh fruit (large apple).
Apple juice or water was available to drink throughout the
day. The average energy intake was 3596 kJ (859 kcal)
comprising 147 g carbohydrate, 23 g protein and 32 g
total fat. Twenty days later (washout period), the proce-
dure was repeated with the assignments reversed.
Of the 24 subjects recruited, 1 female subject was with-
drawn being unable to provide sufficient volume of bloodNutrition Journal 2007, 6:4 http://www.nutritionj.com/content/6/1/4
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and a second female only provided sufficient volume for
triacylglycerol analysis.
Blood specimen collections
To monitor progression of the digestion and absorption
of TAG and individual fatty acids over the postprandial
period, an initial fasted venous blood sample (5 ml) was
collected from each volunteer into heparin tubes followed
by samples at 1.5, 3, 4.5, 6, 7.5 and 9 hour after ingestion
of oil/emulsion. Plasma samples were obtained by centrif-
ugation at 1000 g for 15 min at 4°C and stored at -20°C
until analysis at Cardiff School of Biosciences.
Lipid extraction from plasma and analysis of 
triacylglycerols
Lipids were extracted from 0.5 mL of plasma with chloro-
form:methanol (1:2, v/v) by the method of Garbus et al.
[15]. Triacylglycerols were separated by thin-layer chro-
matography with a mixture of hexane: diethyl ester: acetic
acid (90:30:1, v/v/v) as the elution phase and quantified
by determination of ester bonds [16].
Analysis of total fatty acids from plasma
Fatty acid methyl esters (FAME) were prepared by incuba-
tion for 2 h with 2.5% H2SO4 in dry methanol at 70°C.
FAME were analysed by gas chromatography using an Agi-
lent Technologies 6890 N gas chromatograph, fitted with
a 7683 series injector and a Varian FactorFour™ (VF-5 ms;
30 m × 0.25 mm i.d., 0.25 μm film thickness; Varian Lim-
ited UK, Oxford, UK). The column temperature was held
at 170°C for 3 min, then temperature-programmed to
220°C at 4°C/min. Helium was the carrier gas at a flow
rate 2 ml/min. The fatty acid esters were identified by
comparison of their retention times with authentic stand-
ards and pentadecanoate (C15:0) was used as an internal
standard. Fatty acid standards were obtained from Nu-
Chek Prep. Inc. (Elysian, MN, USA).
Statistical analysis
For all parameters, the area under the concentration curve
(AUC) was calculated by subject and period by means of
the trapezoidal rule after correction for the baseline con-
centration of lipids. AUC represents the integration of
absorption and clearance of a triacylglycerol or fatty acid.
The AUCs were then analysed by an ANOVA model with
repeated measurements taking into account the cross-over
design. In the ANOVA model, Treatment (oil or emul-
sion), Period (Day 0 and Day 20) and Sequence (oil-
emulsion or emulsion-oil) were introduced as fixed effects
and subject as a random effect. Reported P-values are two-
sided, and all statistical analyses were carried out by using
the Statistical Analysis System (SAS) version 9.1 (SAS
Institute, Inc., Cary, NC, USA). There was no statistically
significant interaction between Sequence and Treatment
or between Period and Treatment.
Results
Analysis of the baseline plasma concentrations of total
TAG and individual fatty acids for the oil and the emul-
sion groups at Day 0 and Day 20 indicated that these two
populations were comparable (Table 2). It was also found
that the two treatment sequences were similar (results not
shown).
Table 1: Fatty acid composition of the oil mixture (natural and emulsified forms).
Fatty acid wt %
Myristic acid (14:0) 0.15
Palmitic acid (16:0) 3.7
Palmitoleic acid (16:1) 0.48
Stearic acid (18:0) 3.8
Oleic acid (18:1 n-9) 10.4
Vaccenic acid (18:1 n-7) 1.25
Linoleic (18:2 n-6) 9.5
alpha-Linolenic acid [ALA] (18:3 n-3) 18.2
gamma-Linolenic acid [GLA] (18:3 n-6) 8.3
Stearidonic acid (18:4 n-3) 0.75
Eicosadienoic acid (20:2 n-6) 0.25
Arachidonic acid [ARA] (20:4 n-6) 0.9
Tetracosapentaenoic acid (20:4 n-3) 0.75
Eicosapentaenoic acid [EPA] (20:5 n-3) 16.8
Adrenic acid (22:4 n-6) 0.1
Docosapentaenoic acid (22:5 n-3) 2.7
Docosahexaenoic acid [DHA] (22:6 n-3) 11.0
*Others 10.91
*Consist of fatty acids comprising no more than 1.5% of total fatty acid contentNutrition Journal 2007, 6:4 http://www.nutritionj.com/content/6/1/4
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The rate and total extent of TAG absorption for the two
treatment groups is illustrated in Figure 1 and it can be
seen that both were greater for the emulsion group than
the oil group with a significantly lower total absorption of
TAG for the oil group (AUC difference between oil and
emulsion groups: 904.20 hr. μmol/l) with the ratio
between the emulsion and oil group being 60.4% (P =
0.0182; 95% CI of 169.9 to 1638.5).
The difference seen in plasma TAG levels between the oil
and emulsion groups is explained largely by an improved
absorption of the omega-3 PUFAs and GLA for the emul-
sion group compared to that observed with the oil group.
Particularly noteworthy is the observation that the
absorption of EPA and DHA for the non-emulsified oil
group was only 33.6% and 44.3% respectively of that
observed for the emulsified oil group (Table 3).
Comparison of the absorption of the PUFAs for both oil
and emulsified oil groups is shown in Figure 2 and it can
be seen that the plasma levels of the PUFAs in the emul-
sion group increased more rapidly than with the oil group
in all cases and that increased total absorption of PUFAs,
as determined by AUC, was observed for the emulsion
group. There were no significant differences between the
two groups for the extent of absorption of either the satu-
rated fatty acids (SFA) C16:0 and C18:0, the monounsatu-
rated fatty acid (MUFA) C18:1, n-9 or the PUFA C18:2, n-
6 (Figure 3) but there was a trend towards a more rapid
postprandial reduction in the plasma concentration of
these fatty acids in the emulsion group which reached sig-
nificance when compared with the oil group with regard
to total AUC for palmitic acid (C16:0) P = 0.0319 (95%
CI of -864.8 to -43.5).
Discussion
In this feeding study with a test meal comprising approx-
imately 35% of the calories as fat (either as the mixed oils
or the emulsified version of the oils) it has been found
that the extent of both the postprandial plasma TAG
absorption and also of the individual fatty acids EPA,
DHA, ALA, and GLA was significantly higher in the group
receiving the emulsified oil mixture compared with the
group receiving the non-emulsified form. However, no
significant differences were observed for the absorption of
the other major dietary fatty acids. These results support
previous work from our laboratory which found that the
emulsification of fish oil increased both the rate and total
postprandial absorption of EPA and DHA (unpublished
data).
In a small acute feeding study where the test meal com-
prised solely fish oils or emulsified fish oils, the absorp-
tion of n-3 fatty acids from fish oils was six times greater
when presented in an emulsified form, indicating the
potential benefits from emulsification [12]. Conversely,
no differences were found in a second acute feeding study
[14] where the fish oil or emulsified fish oil content of the
total fat intake in the test meal (providing approximately
60% of calories as fat) represented about 24% of the total
fat content; the remaining 76% of the fat consisted prima-
rily of emulsified dietary fats. Under these conditions
there were no significant differences in the absorption of
the n-3 fatty acids and the authors concluded that the
composition of the total fat content of the test meal had
influenced the comparative absorption of the fatty acids.
Our own laboratory work (not shown) suggests that mix-
ing non-emulsified fish oil with a high background level
of other emulsified dietary fats confounds the comparison
of absorption of emulsified and non-emulsified fish oil.
Several factors have been identified that could contribute
a potential for the depressed absorption of omega-3 fatty
acids which could be abrogated by pre-emulsification.
This includes the nature of the test meal and background
diet [17], the influence of droplet size of the oil emulsion
[18], the inherent resistance of longer chain fatty acids,
Table 2: Comparison of the baseline plasma concentrations of total TAG and individual fatty acids.
Lipid Component Mean plasma concentration at Day 0 Mean plasma concentration at Day 20
Palmitic acid (16:0) 603.1 ± 215.5 617.9 ± 173.8
Stearic acid (18:0) 168.8 ± 53.6 179.1 ± 45.9
Oleic acid (18:1 n-9) 536.0 ± 186.9 564.2 ± 142.4
Linoleic acid (18:2 n-6) 780.5 ± 281.8 816.0 ± 239.3
α Linolenic acid (18:3 n-3) 16.7 ± 8.1 17.1 ± 6.4
γ Linolenic acid (18:3 n-6) 12.0 ± 7.7 11.6 ± 7.4
Eicosapentaenoic acid (20:5 n-3) 25.7 ± 17.5 33.9 ± 21.8
Docosahexaenoic acid (22:6 n-3) 61.4 ± 26.9 73.0 ± 34.6
Triacylglycerols 536.8 ± 182.5 533.7 ± 157.4
Fatty acid data are expressed as mean (mg/l) ± SD for Day 0 and Day 20 (n = 22). Triacylglycerol data are expressed as mean (μmol/l) ± SD for Day 
0 and Day 20 (n = 23).
SD – standard deviation; n – number of subjectsNutrition Journal 2007, 6:4 http://www.nutritionj.com/content/6/1/4
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especially EPA and DHA, to pancreatic lipase [19] and the
delay in the enterocyte re-synthesis of TAG [20].
Chen et al [21] found that there was a significant reduc-
tion in the level of fatty acids recovered from the lymph of
rats fed a fish oil diet compared with a corn oil diet and
Zampelas et al [22] found acute feeding of a fish oil or a
plant oil mixture caused an immediate postprandial
reduction in plasma TAG levels in the fish oil group. How-
ever, Harris et al [17] found that prolonged feeding of a
background diet high in fish oil was necessary to cause
reduced plasma TAG recovery.
It has been found that lowered pancreatic lipase activity
occurs with triglycerides comprising high proportions of
EPA and DHA in the sn1 and sn3 positions [7,23] result-
ing in slower lipolysis of omega-3 fatty acids. The fish oil
used in our study had a distribution of EPA and DHA in
the sn1 and sn3 positions of 80% and 34% respectively,
suggesting that the enzymatic release of EPA in particular
may have been retarded. It is interesting that, in this study,
the greater absorption of EPA occurred in the emulsified
form, and it is tempting to speculate that the effect of
emulsification may have been to improve the rate of reac-
tion of pancreatic lipase on the release of EPA and DHA
from the sn-1 and sn-3 positions. More research is neces-
sary to confirm this hypothesis.
Ikeda et al [20] proposed that inefficiency in the lipolysis
of EPA and DHA could delay or lower the transfer of
MAGs and FFAs into the enterocyte, limiting the supply/
availability of sn2-MAG necessary for the re-synthesis of
TAG for incorporation into chylomicrons; this could
account for the lower levels of omega-3 fatty acids with
the non-emulsified oil group.
However, it is feasible that the rate and extent of absorp-
tion of long chain PUFAs may depend as much on the
degree of emulsification as on enzymic lipolysis. Borel et
al [13] showed greater gastric lipase activity with a fine
emulsion than with a coarser one and Armand et al [18]
comparing fine and coarse emulsions of mixed fish and
Comparison of the concentration of plasma triacylglycerols for oil and emulsion groups Figure 1
Comparison of the concentration of plasma triacylglycerols for oil and emulsion groups. Values represent Mean ± 
SEM of individuals (n = 23) at each time point. -- (blue) oil group; -▪- (red) emulsion group; SEM – standard error of the 
mean; n – number of subjects.Nutrition Journal 2007, 6:4 http://www.nutritionj.com/content/6/1/4
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plant oils found 12.7% – 35.6% disappearance of TAG in
the stomach with the fine emulsion compared with 4.2–
14.8% with the coarse emulsion; for duodenal TAG the
disappearance with fine and coarse emulsions was 56.8–
73.3% and 34.2–46.3% respectively. This suggests that
the efficiency of both the lingual/gastric and pancreatic
Table 3: Comparison of AUCs for individual PUFA.
PUFA Oil group 
AUC (hr.mg/
l)
Emulsion 
group AUC 
(hr.mg/l)
Difference 
(hr.mg/l)
oil/emulsion 
ratio × 100 
(%)
95% CI P – value
Lower Limit Upper Limit
GLA 96.2 139.8 43.5 68.8 0.1 86.9 0.0493
ALA 187.2 284.2 97.0 65.9 22.1 171.9 0.0137
EPA 139.3 414.2 274.9 33.6 175.5 374.3 <0.0001
DHA 97.1 219.4 122.3 44.3 9.2 235.3 0.0355
AUC values are given as Least Square Mean for AUC which is a mean value of total AUC adjusted by the period and sequence.
ANOVA model with repeated measurements taking into account of the cross-over design was used to test for a significant difference in the effect 
of treatment.
*number of subjects = 22; PUFA – polyunsaturated fatty acid
Comparison of the concentration of plasma polyunsaturated fatty acids for oil and emulsion groups Figure 2
Comparison of the concentration of plasma polyunsaturated fatty acids for oil and emulsion groups. Values rep-
resent Mean ± SEM of individuals (n = 22) at each time point. -- (blue) oil group; -▪- (red) emulsion group. ALA – α Linolenic 
acid; GLA – γ Linolenic acid; EPA – Eicosapentaenoic acid; DHA – Docosahexaenoic acid. SEM- standard error of the mean; n 
– number of subjects.Nutrition Journal 2007, 6:4 http://www.nutritionj.com/content/6/1/4
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lipases is improved with the presentation of the oil in a
highly emulsified form. The emulsified version of the oil
mixture in this study had a median droplet size of 1.3 μm
and the profiles for the absorption of the emulsion mix-
ture differ from those for the oil mixture (Figure 3) with
more rapid and extensive absorption occurring with the
emulsion.
Plasma fatty acid concentrations for oil (A) and emulsion (B) groups Figure 3
Plasma fatty acid concentrations for oil (A) and emulsion (B) groups. Data given as mean for concentration of indi-
viduals (n = 22) at each time point. A – oil group; B – emulsion group. -- (green) palmitic acid; -▪- (blue) stearic acid; -▲- (yel-
low) oleic acid; -x- (red) linoleic acid. SEM – standard error of the mean; n – number of subjects.Nutrition Journal 2007, 6:4 http://www.nutritionj.com/content/6/1/4
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One further possible explanation for the increased levels
of plasma EPA and DHA with the emulsions could be the
increased contribution from endogenous fatty acids par-
ticularly from biliary acids. Whilst this possibility cannot
be ignored, studies suggest that the contribution of endog-
enous EPA and DHA to their total post-prandial levels is
minimal [24].
We therefore believe that the lower absorption observed
with the oil group could be explained by insufficient
emulsification of the oil during the digestion of the oil
leading to reduced enzymic lipolysis of the longer chain
PUFAs, particularly EPA and DHA. This insufficiency
could have led to both a delay and a reduction in the
incorporation of these fatty acids into chylomicrons with
the consequent reduction in the postprandial TAG con-
centrations observed. Pre-emulsification of the oil prior to
ingestion reduces droplet size and enables improved
lipolysis, as reported by Armand et al [18], resulting in the
significantly improved absorption recorded with the
emulsion group. Interestingly, no differences were found
between the groups for the digestion and absorption (as
determined by AUC) for the SFA, MUFA and PUFA (18:2
6) suggesting that the improved absorption conferred by
pre-emulsification is restricted to the longer chain PUFAs,
particularly the omega-3 family. This is an important
observation because, with typical daily intakes of omega-
3 fatty acids being less than 5% of total fat intake, the
potential for a pro-atherogenic response based on
increased absorption of these particular fatty acids in
unlikely.
We observed a trend towards an accelerated reduction in
plasma levels of the SFAs, MUFA and PUFA 18:2.6 with
the emulsified oil group, which reached significance with
palmitic acid suggesting greater clearance from the chy-
lomicrons was occurring. In support of this, Park et al [25]
and Zampelas et al [22] have shown that elevated levels of
plasma EPA and DHA resulting from acute feeding induce
an increase in the activity of lipoprotein lipase (LPL)
which is the enzyme responsible for chylomicron TAG
degradation and clearance. Moreover, lipoprotein lipase is
known to preferentially hydrolyse non omega-3 fatty
acids from TAG rich chylomicrons [26].
In our study, the results obtained suggest that the elevated
level of EPA and DHA with the postprandial plasma TAG
of the emulsified group may have influenced the LPL
activity thereby contributing to the accelerated rate of the
fatty acid removal observed. The effect of acute feeding of
EPA and DHA on LPL has also been observed with the
chronic feeding of EPA and DHA resulting in increasing
levels of TAG clearance and leading to the clinically rele-
vant observation of omega-3 fatty acids reducing plasma
TAG levels [25].
Conclusion
The study reported here shows that pre-emulsification of
an oil mixture increases the absorption of the longer chain
more highly unsaturated fatty acids especially EPA and
DHA, but not of the shorter chain less unsaturated fatty
acids.
As there is now general guidance to the population in the
UK and elsewhere to increase the dietary intake of omega
– 3 fatty acids, either by increased consumption of oily
fish or by use of fish oil supplements, these results suggest
that the pre-emulsification of these supplemental fish oils
would significantly improve their absorption.
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